Angiotensin Receptor Blockers and Stroke Therapy | Zendy

Geoffrey A. Donnan | Zendy; Stephen M. Davis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Angiotensin Receptor Blockers and Stroke Therapy

Author(s) -

Geoffrey A. Donnan,

Stephen M. Davis

Publication year - 2009

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.559070

Subject(s) - medicine , stroke (engine) , blood pressure , angiotensin receptor blockers , epidemiology , cardiology , renin–angiotensin system , mechanical engineering , engineering

Blood pressure remains the single most important modifiable risk factor for primary and secondary stroke prevention. There have been endless arguments about the possibility of specific class effects for stroke prevention with much of this debate focused on various mechanisms of blockade of the renin–angiotensin system versus the generic effect of blood pressure-lowering. As indicated by the eloquent arguments …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research